The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib
CONCLUSION: Danusertib, a pan-Aurora kinase inhibitor, is predicted to be used as a potential agent in pancreatic cancers due to its antitumor and anti-metastatic effect.PMID:38454247 | PMC:PMC10895890 | DOI:10.5152/tjg.2024.22319 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Erkan Alaba ş Ahmet Ata Özçimen Source Type: research
